STOMORGYL PA, 100 000 UI/16,67 mg, tabletten voor katten en honden
STOMORGYL PA, 100 000 UI/16,67 mg, tabletten voor katten en honden
Authorised
- Metronidazole
- Spiramycin
Product identification
Medicine name:
STOMORGYL PA, 100 000 UI/16,67 mg, tabletten voor katten en honden
STOMORGYL PA, 100 000 UI/16,67 mg, comprimés pour chats et chiens
STOMORGYL PA, 100 000UI/16,67 mg, Tabletten für Katzen und Hunde
Active substance:
- Metronidazole
- Spiramycin
Target species:
-
Cat
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Metronidazole16.67/milligram(s)1.00Tablet
-
Spiramycin100000.00/international unit(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Cat
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01RA04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- Stomorgyl PA 3 10 Packaging Tablet
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France SCS
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V127775
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
How useful was this page?:
